| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 160.62B | 155.52B | 147.70B | 142.53B | 126.16B |
| Gross Profit | 65.82B | 63.48B | 60.45B | 59.07B | 49.19B |
| EBITDA | 35.24B | 32.91B | 32.99B | 35.04B | 27.99B |
| Net Income | 14.33B | 13.44B | 14.31B | 16.53B | 10.99B |
Balance Sheet | |||||
| Total Assets | 267.70B | 257.26B | 250.12B | 228.85B | 209.76B |
| Cash, Cash Equivalents and Short-Term Investments | 52.35B | 55.88B | 57.97B | 46.70B | 46.90B |
| Total Debt | 44.96B | 49.10B | 28.68B | 25.57B | 30.75B |
| Total Liabilities | 73.84B | 77.84B | 55.48B | 52.01B | 54.95B |
| Stockholders Equity | 180.81B | 166.63B | 181.56B | 164.66B | 143.81B |
Cash Flow | |||||
| Free Cash Flow | 12.06B | 13.05B | 12.75B | 11.57B | 21.43B |
| Operating Cash Flow | 26.39B | 28.56B | 23.33B | 20.18B | 26.98B |
| Investing Cash Flow | -13.98B | -21.74B | -8.54B | -12.17B | -6.96B |
| Financing Cash Flow | -15.04B | -7.99B | -3.83B | -14.74B | -14.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.83B | 13.22 | ― | 3.89% | 1.33% | 29.73% | |
78 Outperform | ¥288.85B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
77 Outperform | ¥20.97B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
72 Outperform | ¥254.64B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥117.97B | 26.06 | 2.64% | 2.30% | -4.11% | 46.76% | |
50 Neutral | ¥12.82B | -0.13 | ― | 6.98% | -11.46% | 43.93% |